1. Home
  2. Law to punish husbands after instant talaq will be a New Year gift for Muslim women: Modi

Law to punish husbands after instant talaq will be a New Year gift for Muslim women: Modi

coastaldigest.com news network
January 29, 2018

Prime Minister Narendra Modi on Monday made a "humble request" to all political parties to help pass the bill on instant triple talaq in the Budget session of Parliament, saying it would be a New Year gift for Muslim women.

Speaking to reporters outside Parliament House, Modi, who is also the husband of helpless Jashodaben, said that despite his government's efforts and people's expectations the triple talaq bill could not be passed in the last session.

He said though there should be no politics on the issue as it relates to the rights of Muslim women, the Bill could not be passed.

While the so called Muslim Women (Protection of Rights on Marriage) Bill, 2017, sailed through the Lok Sabha, it is pending in the Rajya Sabhja as several opposition parties demanded that it be referred to a select committee. The Budget session of Parliament got underway today.

While the government maintains that the bill is meant to ensure “gender justice and gender equality” for married Muslim women, the Muslim leaders across country including women claim that it violates minority rights. Social activists, too, have objected to the bill, questioning the need to criminalise a practice declared "void" by the Supreme Court. AIMIM president Asaduddin Owaisi has opined that triple talaq bill was a ploy to send Muslim men to jail.

Here’s a look at what The Muslim Women (Protection of Rights of Marriage) Bill, 2017 provides for:

— Under proposed bill, a Muslim man who resorts to Talaq-e-Biddat or instant talaq would be jailed for three years.

— The custody of any minor children from the marriage would be granted to the woman and legally husband loses rights on his kids (even if the woman was a murderer or child abuser)

— It makes instant divorce a non-bailable offence which can lead to an imprisonment of up to three years upon conviction.

— It also makes it mandatory for the husband to pay maintenance to his wife and child support towards any children (even if the woman was a billionaire and the man was a beggar).

Comments

ALTHAF MAHAMMED
 - 
Monday, 29 Jan 2018

  1. Pakoda Business is also a gift from Fenku

shaji
 - 
Monday, 29 Jan 2018

Thanks for the bill.  If our PM is a true indian, he should go to jail first respecting the Bill coz he has deserted his wife for no reason.   Secondly, why only appeasing muslim women.  How about Hindu sisters.  There are lakhs of Hindu women who are deserted by their husbands.   govt should also support muslim women by allowing them to marry more than one time like the men and Hindu women should be allowed to have 6 husbands like their Mother Draupadi from Mahabharatha.    When is our PM going to jail respecting the law he is going to introduce in Rajya Sabha.   Let us celebrate it. 

Syed Iftekhar Ahmad
 - 
Monday, 29 Jan 2018

Why not the same punishment to the PM himself?

Jasho
 - 
Monday, 29 Jan 2018

When our bhabhi Jashodaben will get such a wonderful gift?

Ismail Thafseer
 - 
Monday, 29 Jan 2018

Dear Mr. PM,

 

We support your decision but first you are the one who should get punish for leaving your wife and not taking care of her. 

 

Democracy died under your leadership.

Jashoda
 - 
Monday, 29 Jan 2018

Minority appeasement.. Shame on PM 

Why only gift for muslim women.. Why not hindu women too?

 

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 29,2020

Mumbai, Mar 29: Virologist Minal Dakhave Bhosale led from the front to create India's first coronavirus testing kit even when she was in the last stage of her pregnancy.

Bhosale's efforts paid the price with her team delivering the testing kit in a record time of six weeks.

Bhosale gave birth to a baby girl just a day before submitting the kit to the authorities for evaluation.

"It was like giving birth to two babies," Bhosale told PTI over the phone.

The virologist said both the journeys - that happened in parallel - were not without challenges.

"There were complications in the pregnancy while work on the test kit was on. The baby was delivered through cesarean," she said.

Bhosale said she felt that it was the right time to serve the people to help them in combating the coronavirus threat.

"I had been working for five years in this field and if I don't work in emergency situations when my services are needed the most, then what is the use?" she said.

Though Bhosale was not able to visit the office due to the pregnancy, she was guiding a team of 10 persons working on the project at Mylab Discovery in Pune.

The strong bonds forged with the team over the years and their support made it possible, she said.

Company's co-founder Shrikant Patole said just like drug discovery, test kits too go through a lot of quality checks to improve the precision.

He credited Bhosale for the success of the project.

The COVID-19 testing kit delivered by Bhosale's team will reduce the time taken for delivering a result to 2.5 hours from the prevalent practice of eight hours.

A pioneering approach to testing without compromising on the results was adopted, Bhosale said.

The Maylab test kit will cost Rs1,200, a quarter of Rs 4,500 per kit that the government has been spending on testing so far.

"I'm happy that I could do something for the country," Bhosale said.

As of Friday, only 27,000 of the 1.3 billion people were tested for the virus in the country.

According to experts, high scale testing is essential because it alone can ensure an early diagnosis of COVID-19 and lower down the fatalities.

The company is confident of ramping up the capacity at its plant in Lonavala to deliver 100,000 kits a week, Patole said.

He said the authorities are helping the company, including giving priority for shipping of the raw materials.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 5,2020

Thiruvananthapuram, April 5: Kerala Health Minister KK Shailaja on Sunday said that the state's preparations for containment of COVID-19 were satisfactory and added that PCR tests were going on in nine laboratories, in which upwards of eight thousand samples have been tested so far.

"Our strategy for the containment of COVID-19 is satisfactory. We are yielding good results from our strategy for tracing, isolation, testing & treatment. PCR test is going on in 9 laboratories. We have tested more than 8000 samples so far," Shailaja told ANI here.

She further said that the state government wanted to implement Rapid test in Kerala and added that they had ample PPEs and N95 masks.

"We want to implement Rapid Test in Kerala. Yesterday, we got 2000 kits; Right now, we have sufficient PPEs and N95 masks. If the number of COVID19 cases increases in the coming weeks then we will need more equipment," Shailaja said.

Keeping up with the need of the hour, the new administrative block of Kasaragod Medical College will soon be converted into a COVID-19 hospital for providing better treatment facilities to the coronavirus patients.

A team constituting 26 doctors and medical staff of the Government Medical College, Thiruvananthapuram will join the efforts of converting the new administrative block into a COVID-19 Hospital in Kasaragod on Sunday.

The total number of COVID-19 positive cases rose to 3,374 in India on Sunday, as per the data provided by the Ministry of Health and Family Welfare.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.